Form 4: Integra LifeSciences Director Keith Bradley Reports Changes in Beneficial Ownership
SEC Form 4
Director Keith Bradley reported changes in beneficial ownership of Integra LifeSciences Holdings Corp shares, including acquisitions and disposals, according to a Form 4 filing.
Summary
- On May 9, 2024, Keith Bradley acquired 8,696 shares of Integra LifeSciences Holdings Corp.
- Following this acquisition, Mr. Bradley directly owns 70,175 shares.
- On May 12, 2024, Mr. Bradley disposed of 202 shares at a price of $25.99.
- On May 12, 2024, Mr. Bradley disposed of 37 shares at a price of $25.99.
- Following these disposals, Mr. Bradley directly owns 69,936 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing changes in beneficial ownership, which is neutral in sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The change in share ownership may be of interest to shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Keith Bradley acquired 8,696 shares of Common Stock. |
| 05/12/2024 | Keith Bradley disposed of 202 shares of Common Stock at $25.99. |
| 05/12/2024 | Keith Bradley disposed of 37 shares of Common Stock at $25.99. |
| 05/13/2024 | Date of signature by Attorney-in-Fact, Eric Schwartz. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.